Thus, identification of factors that upregulate APOL1 expression in lupus is critical for designing new therapies aimed to prevent or reduce the severity of kidney damage in individuals expressing the APOL1 risk alleles. The gene discussed is APOL1; the disease is systemic lupus erythematosus.